Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ATP-150 by Boehringer Ingelheim International for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
ATP-150 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to...